We could not find any results for:
Make sure your spelling is correct or try broadening your search.
London-based specialist drug discovery and development company - Says its preclinical research program focused on P140 ...
Immupharma PLC 09 January 2025 ...
Immupharma PLC 08 January 2025 08 January 2025 ImmuPharma PLC ("ImmuPharma" or the "Company") IMMUPHARMA at JP MORGAN CONFERENCE and BIOTECH SHOWCASE 11-16 JAN 2025, SAN FRANCISCO ...
Immupharma PLC 23 December 2024 23 December 2024 ImmuPharma PLC ("ImmuPharma" or the "Company") Change of Auditor ImmuPharma PLC (LSE: IMM), the specialist drug discovery and...
Immupharma PLC 10 December 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
Immupharma PLC 04 December 2024 ...
ImmuPharma PLC on Monday expressed optimism about the potential of its pipeline, after narrowing pretax loss in the f ...
ImmuPharma PLC said on Monday it had extended its warrants in Incanthera PLC for the second time, valid now until Mar ...
Immupharma PLC 09 September 2024 ...
Immupharma PLC 09 September 2024 RNS: RELEASE | 9 September 2024 ImmuPharma PLC ("ImmuPharma" or the "Company") INTERIM RESULTS for the six months ended 30 June 2024 ImmuPharma PLC...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -1.75953079179 | 3.41 | 4.68 | 2.4 | 26083282 | 3.46189497 | DE |
4 | 2.15 | 179.166666667 | 1.2 | 4.68 | 1.03 | 14471903 | 3.37408497 | DE |
12 | 1.57 | 88.202247191 | 1.78 | 4.68 | 0.85 | 5593933 | 2.90918638 | DE |
26 | 1.35 | 67.5 | 2 | 4.68 | 0.85 | 3128827 | 2.64538206 | DE |
52 | 1.5925 | 90.6116642959 | 1.7575 | 4.68 | 0.83 | 2624793 | 2.33597746 | DE |
156 | -3.65 | -52.1428571429 | 7 | 9.5 | 0.83 | 1880877 | 3.12136156 | DE |
260 | -11.25 | -77.0547945205 | 14.6 | 21.3 | 0.83 | 1583091 | 5.429035 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions